EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases

Ghadeer K Dawwas, Alexandra Weiss, Brad D Constant, Lauren E Parlett, Kevin Haynes, Jeff Yufeng Yang, Colleen Brensinger, Qufei Wu, Virginia Pate, Michele Jonsson Funk, Douglas E Schaubel, Andres Hurtado-Lorenzo und 2 weitere

Inflammatory Bowel Diseases · 05.12.2023 · 29 (12) · 1993-1996

DOI: 10.1093/ibd/izad053 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 12.04.2023. Verfasst von Ghadeer K Dawwas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Medicare, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ACL HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To facilitate inflammatory bowel disease (IBD) research in the United States, we developed and validated claims-based definitions to identify incident and prevalent IBD diagnoses using administrative healthcare claims data among multiple payers.

Methods

We used data from Medicare, Medicaid, and the HealthCore Integrated Research Database (Anthem commercial and Medicare Advantage claims). The gold standard for validation was review of medical records. We evaluated 1 incidence and 4 prevalence algorithms based on a combination of International Classification of Diseases codes, National Drug Codes, and Current Procedural Terminology codes. The claims-based incident diagnosis date needed to be within ±90 days of that recorded in the medical record to be valid.

Results

We reviewed 111 charts of patients with a potentially incident diagnosis. The positive predictive value (PPV) of the claims algorithm was 91% (95% confidence interval [CI], 81%-97%). We reviewed 332 charts to validate prevalent case definition algorithms. The PPV was 94% (95% CI, 86%-98%) for ≥2 IBD diagnoses and presence of prescriptions for IBD medications, 92% (95% CI, 85%-97%) for ≥2 diagnoses without any medications, 78% (95% CI, 67%-87%) for a single diagnosis and presence of an IBD medication, and 35% (95% CI, 25%-46%) for 1 physician diagnosis and no IBD medications.

Conclusions

Through a combination of diagnosis, procedural, and medication codes in insurance claims data, we were able to identify incident and prevalent IBD cases with high accuracy. These algorithms can be useful for the ascertainment of IBD cases in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicareInflammatory Bowel DiseasesHumansAgedUnited StatesInsurance Claim ReviewInternational Classification of DiseasesDatabases, FactualAlgorithms

Stichwörter der Autor:innen

IBDICDepidemiologyobservational studyvalidation

Autor:innen und Institutionen

  • Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Carelon Research, Wilmington, DE, USA.
  • Janssen Research and Development, LLC, Titusville, NJ, USA.
  • Center for Pharmacoepidemiology, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Förderung

  • ACL HHS
  • NCATS NIH HHS
  • NIH HHS
  • CDC HHS
  • NIDDK NIH HHS
  • NCCDPHP CDC HHS
  • Centers for Disease Control and Prevention
  • National Institutes of Health

Zitieren

APA

Dawwas, G. K., Weiss, A., Constant, B. D., Parlett, L. E., Haynes, K., Yang, J. Y., Brensinger, C., Wu, Q., Pate, V., Jonsson Funk, M., Schaubel, D. E., Hurtado-Lorenzo, A., David Kappelman, M., & Lewis, J. D. (2023). Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases. Inflammatory Bowel Diseases, 29(12), 1993-1996. https://doi.org/10.1093/ibd/izad053

Vancouver

Dawwas GK, Weiss A, Constant BD, Parlett LE, Haynes K, Yang JY, et al. Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases. Inflammatory Bowel Diseases. 2023;29(12):1993-1996. doi:10.1093/ibd/izad053

BibTeX
@article{Dawwas2023,
  author = {Dawwas, Ghadeer K and Weiss, Alexandra and Constant, Brad D and Parlett, Lauren E and Haynes, Kevin and Yang, Jeff Yufeng and Brensinger, Colleen and Wu, Qufei and Pate, Virginia and Jonsson Funk, Michele and Schaubel, Douglas E and Hurtado-Lorenzo, Andres and David Kappelman, Michael and Lewis, James D},
  title = {Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  volume = {29},
  number = {12},
  pages = {1993--1996},
  doi = {10.1093/ibd/izad053}
}
Kostenlos starten →